Momenta Pharmaceuticals Inc.

(MNTA) Trade

By |

Profile

Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While biosimilar versions of Humira and Eylea are in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including M281, M254, and M230, are in development to treat rare autoimmune diseases.

Contact Information

Website: www.momentapharma.com
Email: IR@momentapharma.com
Main Phone: +1 617 491-9700
Address: 301 Binney Street
Address 2: Suite 3100, PO Box 49143
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Craig A. Wheeler
Employees: 131
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More


Gathering Data... Please wait

Profile

Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While biosimilar versions of Humira and Eylea are in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including M281, M254, and M230, are in development to treat rare autoimmune diseases.

Contact Information

Website: www.momentapharma.com
Email: IR@momentapharma.com
Main Phone: +1 617 491-9700
Address: 301 Binney Street
Address 2: Suite 3100, PO Box 49143
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Craig A. Wheeler
Employees: 131
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More
$ 14.15 $ 0.46 (3.36%)
Last Price 14.15 Change $ 0.46 Change % 3.36 Tick N/A
Bid 12.06 Bid Size 100.00 Ask 14.82 Ask Size 100.00
Open 13.77 High 14.62 Low 13.75 Prev Close 13.69
Last Trade Volume 423,607 52 Wk Hi 16.11 52 Wk Low 9.51
Market Cap 1.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 98,707,302.00 EPS (TTM) -2.33 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 48 108
Number of Buys 17 29
Number of Sells 31 79
Net Activity -26548 -47683
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Young Kwon 1,000
Craig A. Wheeler 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 23 23 23 23
Low Target Price Estimate 15 15 15 16
Mean Target Price Estimate 18 18 18 20.67
Standard Deviation 4.36 4.36 4.36 4.04
Date of Most Recent Estimate 05/09/18 05/09/18 05/09/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 2 2 2
Moderate Buy 0 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 3 2.6 2.6 2.6